TCL Archive Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival October 25, 2013
TCL Archive P-32 Ingestion At NCI Attracts Attention; Similar Cases Seen At Labs In The Past November 3, 1995
TCL Archive NCI advisors table proposed $186.5 million nanotechnology research program. NCI proposed to fund three to five “centers for cancer nanotechnology excellence,” a coordinating center, and training programs. Board members said they needed more time, information, to make decision. NCI director asked board to “think big” about nanotechnology. Deputy director called nanotechnology program “transformational.” July 2, 2004
TCL Archive Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change? January 20, 2006
